Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease

Mov Disord. 2020 Sep;35(9):1495-1496. doi: 10.1002/mds.28231. Epub 2020 Aug 21.

Author

Cristian Follmer¹

Affiliation

¹ Laboratory of Biological Chemistry of Neurodegenerative Disorders, Department of Physical Chemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

No abstract available

Keywords: Parkinson's disease; coronavirus; microbiome; neuroinflammation; α-synuclein.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bacterial Translocation / immunology
COVID-19 / complications*
COVID-19 / microbiology
Dysbiosis / complications*
Enteric Nervous System / physiopathology
Gastrointestinal Microbiome*
Humans
Inflammation
Lipopolysaccharides / metabolism
Lipopolysaccharides / toxicity
Microglia / immunology
Microglia / metabolism
Models, Biological
Neuroimmunomodulation
Parkinson Disease / etiology*
Parkinson Disease / microbiology
Protein Aggregation, Pathological
Risk Factors
SARS-CoV-2 / pathogenicity*
Vagus Nerve / physiopathology
alpha-Synuclein / metabolism

Substances

Lipopolysaccharides
alpha-Synuclein